Orthofix Medical Inc. (NASDAQ:OFIX) Q2 2023 Earnings Conference Call August 8, 2023 4:30 PM ET
Company Participants
Louisa Smith - Vice President of Investor Relations, Gilmartin Group LLC
Keith Valentine - Chief Executive Officer
John Bostjancic - Chief Financial Officer
Conference Call Participants
Mathew Blackman - Stifel Financial Corp.
Jeffrey Cohen - Ladenburg Thalmann & Co. Inc.
David Turkaly - JMP Group LLC
Operator
Ladies and gentlemen, good afternoon. My name is Abby, and I will be your conference operator today. At this time, I would like to welcome everyone to the Orthofix Medical Second Quarter 2023 Earnings Conference Call. Today’s conference is being recorded, and all lines have been placed on mute to prevent any background noise. After the speaker’s remarks, there will be a question-and-answer session. [Operator Instructions]
Thank you. And I will now turn the conference over to Louisa Smith at Gilmartin. You may begin.
Louisa Smith
Thank you, operator, and good afternoon, everyone. Welcome to the Orthofix second quarter 2023 earnings call. Joining me on the call today are President and Chief Executive Officer, Keith Valentine; and Chief Financial Officer, John Bostjancic. During this call, we will be making forward-looking statements that involve risks and uncertainties. All statements other than those of historical facts are forward-looking statements, including any earnings guidance we provide and any statements about our plans, beliefs, strategies, expectations, goals or objectives. Investors are cautioned not to place undue reliance on such forward-looking statements, as there is no assurance that the matter contained in such statements will occur.
The forward-looking statements we will make on today’s call are based on our beliefs and expectations as of today, August 8, 2023. We do not undertake any obligation to revise or update such forward-looking statements. Some factors that could cause actual results to be materially different from the forward-looking statements made by us on the call include risk factors disclosed under the heading Risk Factors in our Form 10-K for the year ended December 31, 2022 and Form 10-Q filed this afternoon, August 8, 2023 as well as additional SEC filings we make in the future.
In addition, on today’s call, we will refer to various non-GAAP financial measures. We believe that in order to properly understand our short-term and long-term financial trends, investors may wish to review these matters as a supplement to the financial measures determined in accordance with U.S. GAAP. Please refer to today’s news release announcing our second quarter 2023 results for reconciliations of these non-GAAP financial measures to our U.S. GAAP financial results.